Nedometinib
Nedometinib (NFX-179) is a selective mitogen-activated protein kinase kinase (MEK1) inhibitor with anticancer and antitumor activity, inhibits MAPK pathway signaling in the skin, inhibits the growth of human squamous cell lines in a dose-dependent manner, and can be used to study malignant tumors.
Product Specifications
CAS Number
2252314-46-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
470.24
Molecular Formula
C17H16FIN4O3
Notes
Research use only, not for human use.
Receptor
MEK
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6424795-01 0.1 mL
LIN28A (Lin-28 Homolog A, Zinc Finger CCHC Domain-containing Protein 1, CSDD1, LIN28, LIN-28, ZCCHC1) (HRP)
Sign In for Pricing
View Details MBS6424795-02 5x 0.1 mL
LIN28A (Lin-28 Homolog A, Zinc Finger CCHC Domain-containing Protein 1, CSDD1, LIN28, LIN-28, ZCCHC1) (HRP)
Sign In for Pricing
View Details 
041669-HRP 200 µL
SGMS2, CT (SGMS2, SMS2, Phosphatidylcholine:ceramide cholinephosphotransferase 2, Sphingomyelin synthase 2) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details